focus -WSS

focus

author：leisure time 2025-10-01 01:50:21 - browse：59

Illustration of a dollar sign with arrows. — Adobe

Health insurers are telling shareholders that they are ramping up the use of artificial intelligence and are hiring talent to implement the technology across their organizations. They say their artificial intelligence models can increase efficiency and “cut costs,” but they refused to discuss what models they’re using, how those models were developed, or exactly what they’re using them for.

Centene, for instance, says, it is “investing in artificial intelligence and machine learning technologies to improve the health of our members and contain rising healthcare costs.” The insurer, whose plans cover more than 28 million Americans, noted that its large footprint, particularly in government-sponsored programs, puts it “in a unique position to use data to develop models that predict a wide range of health outcomes.”

A STAT review of regulatory filings from publicly traded health insurers showed that several of them, including Elevance, Molina, and Cigna, are investing in AI with the goal of saving money. Elevance has hired nearly 500 people to work exclusively on AI. However, all five of the insurers STAT contacted declined to elaborate on how they are using AI.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： For longer

hotspot

WSS

Investigation reveals sickle cell patients pressured into sterilizations

UnitedHealth argues against case alleging wrongful AI care denials

Roche acquires Telavant from Roivant, adding experimental IBD treatment

UnitedHealth, Optum discontinue NaviHealth name

Roivant's CEO is a star, but biotech's black hole persists

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Bright Health sells Medicare Advantage business to Molina

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Medical leaders decry Supreme Court decision on affirmative action

Making the case for fair compensation in clinical trials

After affirmative action ruling, medical educators look to 'holistic review'

Listen: More tumult at BIO & coercive care for sickle cell patients

Tori Bowie and the unacceptable rates of Black maternal death

Making the case for fair compensation in clinical trials

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

knowledge

Roivant's CEO is a star, but biotech's black hole persists

How AI can help patients find reliable information about doctors

Health tech investors get more selective as pandemic boom fades

Addressing health care workers' trauma can help fight burnout

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Why a market frenzy over new weight loss drugs defies logic

explore

hotspot

hotspot

entertainment